Amedeo Smart

Free Medical Literature Service

 

Amedeo

Thoracic Surgery
  Free Subscription

Articles published in
Lancet
    April 2024
  1. LI X, Ge Z, Kan J, Anjum M, et al
    Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention in acute coronary syndromes (IVUS-ACS): a two-stage, multicentre, randomised trial.
    Lancet. 2024 Apr 5:S0140-6736(24)00282-4. doi: 10.1016/S0140-6736(24)00282.
    >> Share

  2. DEN DEKKER WK
    Is intravascular imaging the future of percutaneous coronary intervention?
    Lancet. 2024 Apr 5:S0140-6736(24)00430-6. doi: 10.1016/S0140-6736(24)00430.
    >> Share

  3. GE Z, Kan J, Gao X, Raza A, et al
    Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial.
    Lancet. 2024 Apr 5:S0140-6736(24)00473-2. doi: 10.1016/S0140-6736(24)00473.
    >> Share

  4. PARK SJ, Ahn JM, Kang DY, Yun SC, et al
    Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial.
    Lancet. 2024 Apr 4:S0140-6736(24)00413-6. doi: 10.1016/S0140-6736(24)00413.
    >> Share

  5. BOROVAC JA
    Percutaneous coronary intervention for non-obstructive vulnerable plaques.
    Lancet. 2024 Apr 4:S0140-6736(24)00488-4. doi: 10.1016/S0140-6736(24)00488.
    >> Share

    March 2024
  6. WERNLY B, Jung C
    Transfemoral transcatheter aortic valve replacement for pure aortic regurgitation.
    Lancet. 2024 Mar 26:S0140-6736(24)00062-X. doi: 10.1016/S0140-6736(24)00062.
    >> Share

  7. VAHL TP, Thourani VH, Makkar RR, Hamid N, et al
    Transcatheter aortic valve implantation in patients with high-risk symptomatic native aortic regurgitation (ALIGN-AR): a prospective, multicentre, single-arm study.
    Lancet. 2024 Mar 26:S0140-6736(23)02806-4. doi: 10.1016/S0140-6736(23)02806.
    >> Share

  8. LEBRETON G, Leprince P
    Successful heart transplant after 12 h preservation aboard a commercial flight.
    Lancet. 2024;403:1019.
    >> Share

    February 2024
  9. LEE ZS, Ryan N
    Intravascular imaging in percutaneous coronary intervention.
    Lancet. 2024 Feb 21:S0140-6736(23)02686-7. doi: 10.1016/S0140-6736(23)02686.
    >> Share

    January 2024
  10. LANDI A, Pedrazzini G, Wild L, Beele A, et al
    Coronary embolisation of native aortic valve debris during transcatheter aortic valve replacement: mechanical embolectomy and histopathological analysis.
    Lancet. 2024;403:e5-e6.
    >> Share

    December 2023
  11. JIMENEZ DIAZ VA, Iniguez Romo A
    Intracoronary artery visualisation of crystalline sirolimus deposits after drug-coated balloon angioplasty for acute coronary syndrome.
    Lancet. 2023;402:2111-2112.
    >> Share

    November 2023
  12. MESSAS E, Ijsselmuiden A, Trifunovic-Zamaklar D, Cholley B, et al
    Treatment of severe symptomatic aortic valve stenosis using non-invasive ultrasound therapy: a cohort study.
    Lancet. 2023 Nov 13:S0140-6736(23)01518-0. doi: 10.1016/S0140-6736(23)01518.
    >> Share

  13. DI MARIO C, Mattesini A
    Non-invasive high-energy ultrasound: alternative treatment before transcatheter aortic valve implantation?
    Lancet. 2023 Nov 13:S0140-6736(23)02186-4. doi: 10.1016/S0140-6736(23)02186.
    >> Share

    October 2023
  14. VERHEMEL S, Van Mieghem NM
    Revalving to treat transcatheter valve failure.
    Lancet. 2023;402:1500-1501.
    >> Share

  15. KHO SS, Chai CS, Ho RL, Ismail AM, et al
    Pulmonary alveolar microlithiasis-a rare lung disease-diagnosed by transbronchial cryobiopsy.
    Lancet. 2023;402:1356.
    >> Share

    August 2023
  16. MAKKAR RR, Kapadia S, Chakravarty T, Cubeddu RJ, et al
    Outcomes of repeat transcatheter aortic valve replacement with balloon-expandable valves: a registry study.
    Lancet. 2023 Aug 31:S0140-6736(23)01636-7. doi: 10.1016/S0140-6736(23)01636.
    >> Share

  17. CONEN D, Ke Wang M, Popova E, Chan MTV, et al
    Effect of colchicine on perioperative atrial fibrillation and myocardial injury after non-cardiac surgery in patients undergoing major thoracic surgery (COP-AF): an international randomised trial.
    Lancet. 2023 Aug 25:S0140-6736(23)01689-6. doi: 10.1016/S0140-6736(23)01689.
    >> Share

    May 2023
  18. BRADBURY AW, Moakes CA, Popplewell M, Meecham L, et al
    A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisatio
    Lancet. 2023;401:1798-1809.
    >> Share

    April 2023
  19. GAUDINO M, Andreotti F, Kimura T
    Current concepts in coronary artery revascularisation.
    Lancet. 2023 Apr 27:S0140-6736(23)00459-2. doi: 10.1016/S0140-6736(23)00459.
    >> Share

    March 2023
  20. PUSTJENS TFS, Vriesendorp PA, Van't Hof AWJ
    Revascularisation in acute coronary syndromes: change in practice?
    Lancet. 2023 Mar 3:S0140-6736(23)00403-8. doi: 10.1016/S0140-6736(23)00403.
    >> Share

    November 2022
  21. LI Y, Liang Z, Qin L, Wang M, et al
    Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial.
    Lancet. 2022 Nov 4. pii: S0140-6736(22)01999.
    >> Share

    July 2022
  22. MAHMOOD F, Topol EJ
    Digitising heart transplant rejection.
    Lancet. 2022;400:17.
    >> Share

    April 2022
  23. SAJI H, Okada M, Tsuboi M, Nakajima R, et al
    Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial.
    Lancet. 2022;399:1607-1617.
    >> Share

  24. LICHT PB
    When less is more in thoracic surgery.
    Lancet. 2022;399:1574-1575.
    >> Share

  25. SEKULIC SP, Sekulic M
    Atypical arrhythmogenic presentation of giant cell myocarditis diagnosed after heart transplant.
    Lancet. 2022;399:1411.
    >> Share

  26. BORGES FK, Spence J
    Challenging dogma about perioperative warming during non-cardiac surgery.
    Lancet. 2022 Apr 1. pii: S0140-6736(22)00607.
    >> Share

  27. SESSLER DI, Pei L, Li K, Cui S, et al
    Aggressive intraoperative warming versus routine thermal management during non-cardiac surgery (PROTECT): a multicentre, parallel group, superiority trial.
    Lancet. 2022 Apr 1. pii: S0140-6736(22)00560.
    >> Share

    February 2022
  28. THEODOROPOULOS KC, Liakopoulou A, Tsagkaropoulos S, Kassimis G, et al
    Under-sensing by a temporary pacemaker after cardiac surgery and ventricular fibrillation.
    Lancet. 2022;399:677.
    >> Share

  29. BODEN WE, Kaski JC, Al-Lamee R, Weintraub WS, et al
    What constitutes an appropriate empirical trial of antianginal therapy in patients with stable angina before referral for revascularisation?
    Lancet. 2022;399:691-694.
    >> Share

    January 2022
  30. BURKI T
    Pig-heart transplantation surgeons look to the next steps.
    Lancet. 2022;399:347.
    >> Share

    November 2021
  31. SABATINE MS, Bergmark BA, Murphy SA, O'Gara PT, et al
    Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysis.
    Lancet. 2021 Nov 12. pii: S0140-6736(21)02334.
    >> Share

  32. MEHRAN R, Owen R, Chiarito M, Baber U, et al
    A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention: derivation and validation from an observational registry.
    Lancet. 2021 Nov 12. pii: S0140-6736(21)02326.
    >> Share

  33. GAUDINO M, Sanna T, Ballman KV, Robinson NB, et al
    Posterior left pericardiotomy for the prevention of atrial fibrillation after cardiac surgery: an adaptive, single-centre, single-blind, randomised, controlled trial.
    Lancet. 2021 Nov 12. pii: S0140-6736(21)02490.
    >> Share

  34. BELLEY-COTE EP, Devereaux PJ
    PCI versus CABG for left main coronary artery disease: is the jury still out?
    Lancet. 2021 Nov 12. pii: S0140-6736(21)02491.
    >> Share

  35. VAN BOVEN WJ, de Groot JR, Kluin J
    A short cut to prevent postoperative atrial fibrillation.
    Lancet. 2021 Nov 12. pii: S0140-6736(21)02435.
    >> Share

  36. KANG J, Koo BK, Park KW, Shin ES, et al
    Aspirin versus clopidogrel after percutaneous coronary intervention - Authors' reply.
    Lancet. 2021;398:1685-1686.
    >> Share

  37. PAREEK M, Byrne C
    Aspirin versus clopidogrel after percutaneous coronary intervention.
    Lancet. 2021;398:1685.
    >> Share

  38. BYRNE RA, McGovern L
    Angiography-derived quantitative flow ratio guidance of coronary intervention: measure twice, cut once.
    Lancet. 2021 Nov 3. pii: S0140-6736(21)02397.
    >> Share

  39. XU B, Tu S, Song L, Jin Z, et al
    Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial.
    Lancet. 2021 Nov 3. pii: S0140-6736(21)02248.
    >> Share

    October 2021
  40. KIM CJ, Park MW, Kim MC, Choo EH, et al
    Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised tr
    Lancet. 2021;398:1305-1316.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016